NBIX
Neurocrine Biosciences, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -1.3% · posisi baru bersih -4.5% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 642.22K | $90.01M | n/a | −3 |
| Q2 2026 | 152 | 0 | 75.82M | $12.77B | +5 | −6 |
| Q1 2026 | 156 | 0 | 77.10M | $10.14B | +6 | −7 |
| Q4 2025 | 155 | 0 | 77.25M | $10.95B | +1 | n/a |
| Q3 2025 | 22 | 0 | 59.57M | $8.36B | +1 | −2 |
| Q2 2025 | 20 | -1 | 49.44M | $6.21B | +2 | −3 |
| Q1 2025 | 18 | 0 | 22.97M | $2.54B | +1 | −1 |
| Q4 2024 | 18 | 0 | 21.48M | $2.93B | +1 | −1 |
| Q3 2024 | 17 | 0 | 13.43M | $1.55B | n/a | n/a |
| Q2 2024 | 17 | n/a | 11.91M | $1.64B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 12.71M | -1.9% | $1.78B | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 2 | The Vanguard Group ✦ (pasif) | 9.71M | -1.0% | $1.36B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | JPMorgan Chase ✦ | 9.46M | n/a | $1.33B | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 4 | Dodge & Cox ✦ | 5.56M | -0.2% | $780.04M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasif) | 4.35M | -2.7% | $610.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.87M | -7.1% | $402.43M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 2.77M | +83.7% | $388.44M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 8 | Renaissance Technologies ✦ | 2.42M | +2.2% | $339.48M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 2.02M | +3.4% | $283.50M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Morgan Stanley ✦ | 1.83M | n/a | $256.47M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 11 | Wellington Management ✦ | 1.81M | -10.7% | $254.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 977.21K | -18.2% | $137.18M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 793.24K | -61.3% | $111.35M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Goldman Sachs Group ✦ | 609.61K | n/a | $85.58M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 15 | PRIMECAP Management ✦ | 512.26K | -2.2% | $71.91M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 411.66K | +228.9% | $57.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 347.56K | Baru | $48.79M | 0.1% | New | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 136.35K | +49.6% | $19.14M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Marshall Wace ✦ | 97.29K | +133.6% | $13.66M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 20 | Fisher Asset Management ✦ | 94.80K | +8.3% | $13.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 72.34K | -71.6% | $10.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 22 | Bridgewater Associates ✦ | 23.04K | +157.6% | $3.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Two Sigma Investments | $48.79M | 0.1% |
Telah keluar
| Norges Bank | $122.28M | adalah 0.0% |
| Adage Capital Partners | $42.93M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 690 pemegang, 94.09M saham, $12.08B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 826 lbr · $130,051
Officer · 2.31K lbr · $363,285
Officer · 2.15K lbr · $333,030
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi